IM Cannabis Corp. (NASDAQ:IMCC – Get Free Report) shares fell 4.4% on Tuesday . The stock traded as low as $2.23 and last traded at $2.28. 10,149 shares traded hands during mid-day trading, a decline of 91% from the average session volume of 108,357 shares. The stock had previously closed at $2.38.
IM Cannabis Stock Down 4.4 %
The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.52 and a current ratio of 0.69. The company’s fifty day moving average price is $2.59 and its 200-day moving average price is $3.12. The stock has a market cap of $5.08 million, a P/E ratio of -0.47 and a beta of 0.43.
IM Cannabis (NASDAQ:IMCC – Get Free Report) last posted its quarterly earnings data on Wednesday, August 14th. The company reported ($0.17) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.84) by $0.67. IM Cannabis had a negative net margin of 26.46% and a negative return on equity of 97.26%. The company had revenue of $10.78 million for the quarter, compared to analyst estimates of $9.62 million. Equities analysts forecast that IM Cannabis Corp. will post -5.61 EPS for the current year.
Institutional Investors Weigh In On IM Cannabis
About IM Cannabis
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands.
Featured Stories
- Five stocks we like better than IM Cannabis
- With Risk Tolerance, One Size Does Not Fit All
- Why Lennar Stock Could Be the Best Play in the Housing Market
- 3 Fintech Stocks With Good 2021 Prospects
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Financial Services Stocks Investing
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for IM Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IM Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.